For instance, some studies have led to the design of clinical diagnostic tools, such us neprylisin (NEP/CD10), which is a useful immunohistochemical marker in the diagnosis of proximal nephron-derived carcinomas [33]. This evidence concerns the gene MME and carcinoma.